Э К Возный
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Surgery top 5%
- Gastroenterology top 0.5%
- Hematology top 2%
- Co-authors
- Sergei TjulandinYee ChaoC. BoniVladimir MoiseyenkoAlejandro MajlisEric Van CutsemM FodorAdriano Rodrigues
- Topics
- Colorectal Cancer Treatments and Studies (3 papers)Gastric Cancer Management and Outcomes (3 papers)Cancer Treatment and Pharmacology (2 papers)
- Journals
- Journal of Clinical OncologyPubMed
In The Last Decade
Э К Возный
6 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.3k
- Surgery 784
- Gastroenterology 568
- Hematology 440
Countries citing papers authored by Э К Возный
This map shows the geographic impact of Э К Возный's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Э К Возный with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Э К Возный more than expected).
Fields of papers citing papers by Э К Возный
This network shows the impact of papers produced by Э К Возный. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Э К Возный. The network helps show where Э К Возный may publish in the future.
Co-authorship network of co-authors of Э К Возный
This figure shows the co-authorship network connecting the top 25 collaborators of Э К Возный. A scholar is included among the top collaborators of Э К Возный based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Э К Возный. Э К Возный is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 208 | |
| 2 | 158 | |
| 3 | Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Groupbreakdown → | 1480 |
| 4 | 121 | |
| 5 | Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Studybreakdown → | 505 |
| 6 | [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer]. | 1 |
About Э К Возный
Э К Возный is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 6 papers that have together received 2.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Gastroenterology (568 citations), Pulmonary and Respiratory Medicine (1.6k citations) and Oncology (1.3k citations). Э К Возный has collaborated with scholars based in Portugal, Russia and Poland. Frequent co-authors include Sergei Tjulandin, Yee Chao, C. Boni, Vladimir Moiseyenko, Alejandro Majlis, Eric Van Cutsem, M Fodor, Adriano Rodrigues, Manuel Constenla and Jaffer A. Ajani. Their work appears in journals such as Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.